What are the causes of scattered pulmonary cysts and should I obtain a high‑resolution CT (HRCT) of the chest?

Causes of Scattered Pulmonary Cysts and Role of HRCT

Yes, you should obtain an HRCT chest for scattered pulmonary cysts—it is the diagnostic imaging modality of choice and essential for characterizing cyst distribution, morphology, and associated findings to narrow the differential diagnosis and guide management. 1

Why HRCT is Essential

HRCT is the recommended imaging technique for diagnosis, assessment, and follow-up of diffuse cystic lung diseases 1. The technique allows detailed evaluation of:

• Cyst characteristics: Number, size (typically 2-30mm), shape, wall thickness, and distribution
• Background parenchymal changes: Nodules, ground-glass opacities, fibrosis
• Anatomic distribution: Subpleural vs. parenchymal, upper vs. lower lobe predominance
• Associated findings: Lymphadenopathy, pleural disease, emphysema

Technical specifications: Use thin collimation (1mm) with high spatial reconstruction algorithm, either sequential scanning at 1-cm intervals or low-dose spiral multidetector CT 1. Include prone views to distinguish dependent atelectasis from true parenchymal disease 2.

Major Causes of Scattered Pulmonary Cysts

Lymphangioleiomyomatosis (LAM)

• Classic presentation: Women of reproductive age with progressive dyspnea, cough (66-83% of cases), spontaneous pneumothorax, or chylothorax 3
• HRCT findings: Multiple (>10) thin-walled, round, well-defined air-filled cysts distributed evenly throughout lungs with preserved/increased lung volumes 1
• Key feature: No significant interstitial lung disease (except possible multifocal micronodular pneumocyte hyperplasia in tuberous sclerosis) 1
• Additional workup: Abdomino-pelvic CT to identify angiomyolipomas (present in 2/3 of patients) 1

Pulmonary Langerhans Cell Histiocytosis (PLCH)

• Classic presentation: Young adult smokers with cough (50-67%) and dyspnea 3, 4
• HRCT findings: Peribronchiolar nodules combined with irregularly shaped cystic spaces, predominantly upper and middle lobe distribution 3
• Evolution: Early nodular phase progresses to cystic changes, potentially coalescing into cavitated appearance 3
• Critical history: Strong association with tobacco smoking 3

Birt-Hogg-Dubé Syndrome (BHS)

• Genetic disorder with characteristic cyst distribution
• HRCT findings: Multiple thin-walled cysts, often basilar and medial/paramediastinal distribution 5, 6
• Associated features: Renal tumors, skin fibrofolliculomas, family history

Lymphocytic Interstitial Pneumonia (LIP)

• Associated conditions: Sjögren syndrome, HIV, autoimmune disorders
• HRCT findings: Scattered cysts with background ground-glass opacities and centrilobular nodules 5, 6
• Distribution: Typically lower lobe predominant

Other Important Causes

• Desquamative Interstitial Pneumonia (DIP): Cysts with extensive ground-glass opacities, smokers 3, 5
• Pneumocystis jirovecii pneumonia: Cysts with ground-glass opacities in immunocompromised patients 6
• Light-chain deposition disease/Amyloidosis: Cysts with nodules 6
• Pulmonary hydatid cysts: Endemic areas, typically right lower lobe, may be complicated 7, 8

Diagnostic Algorithm Using HRCT

Step 1: Confirm True Cysts vs. Mimics

Distinguish from:

• Centrilobular emphysema (no visible walls)
• Cavities (thick walls, usually infectious/neoplastic)
• Cystic bronchiectasis (follows bronchial distribution)
• Honeycomb cysts (subpleural, uniform size 3-10mm, fibrosis) 5, 6

Step 2: Assess Cyst Distribution

• Subpleural predominance: Consider paraseptal emphysema, bullae, honeycombing from fibrosis 6
• Diffuse parenchymal: LAM, PLCH, BHS, LIP 5, 6
• Upper lobe predominance: PLCH 3
• Lower lobe/basilar: BHS, LIP, usual interstitial pneumonia patterns 5

Step 3: Evaluate Associated Findings

• Nodules present: PLCH (early), LIP, light-chain deposition, amyloidosis 5, 6
• Ground-glass opacities: LIP, DIP, Pneumocystis pneumonia 6
• Normal background parenchyma: LAM, BHS 1, 5
• Preserved/increased lung volumes: LAM 1

Step 4: Integrate Clinical Context

• Demographics: Age, sex (LAM in reproductive-age women)
• Smoking history: PLCH, DIP strongly associated
• Immune status: Pneumocystis in immunocompromised
• Family history: BHS (autosomal dominant)
• Geographic exposure: Hydatid cysts in endemic areas
• Systemic symptoms: Tuberous sclerosis with LAM, autoimmune disease with LIP

Common Pitfalls to Avoid

1. Don't rely on plain chest radiographs alone: HRCT is 34% more sensitive for detecting early parenchymal changes and essential for cyst characterization 2

2. Don't assume all cysts are benign: While solitary incidental cysts may be age-related, multiple/diffuse cysts require systematic evaluation 6

3. Don't miss LAM in women: Even with few cysts (<10), consider LAM if characteristic morphology present—obtain abdominal CT for angiomyolipomas 1

4. Don't forget prone imaging: Essential to distinguish dependent atelectasis from true parenchymal disease in posterior lung fields 2

5. Don't overlook clinical context: HRCT findings must be integrated with exposure history, symptoms, and laboratory findings for accurate diagnosis 9, 10

When Tissue Diagnosis is Needed

Despite characteristic HRCT findings, biopsy may be required when:

• HRCT pattern is atypical or equivocal 3, 10
• Multiple diagnoses remain in differential
• Treatment decisions require histologic confirmation
• Patient has features incompatible with leading diagnosis

HRCT can guide biopsy site selection when tissue confirmation is necessary 10.